- CEO
- Rui Bo Lu
- Full Time Employees
- 8,271
- Sector
- Non-energy minerals
- Industry
- Steel
- Address
- Shui On Centre Hong Kong Hong Kong
- IPO Date
- Jun 28, 2019
- Business
- Impro Precision Industries Limited (1286.HK) is a global leading manufacturer of high-precision, high-complexity and mission-critical casting and machined components for diverse end-markets including automotive, aerospace, medical, energy, construction equipment, agricultural equipment and recreational vehicles. The company, founded in 1998 in Wuxi, China, with global headquarters in Hong Kong since 2011, operates through four main segments: investment casting; precision machining and others; sand casting; and surface treatment, offering customized products such as components for fuel systems, electric fuel injection and exhaust systems, transmission systems, hydraulic orbital motors and tool parts, engine blocks, cylinder heads, emission and engine systems, marine engines and steering systems, motorcycle brakes, exhaust gas recirculation and body systems, motor shafts, turbochargers, and parts for distributed energy engines, electric vehicles, combine harvesters, seeders and tractors. It maintains an integrated business model providing one-stop solutions from tooling design and manufacturing, casting, secondary machining, heat treatment, surface treatment to finishing, with manufacturing plants across China, Mexico, Turkey, Germany and the Czech Republic, and sales offices supporting customers in the Americas, Europe and Asia; key clients include Bosch, Caterpillar, Cummins, Honeywell, HUSCO and Parker Hannifin. In recent developments, the company completed the relocation of its Foshan Ameriforge facility and merger with Nantong Plant No. 12 by end-2024, alongside significant capacity expansions in its Mexico SLP Campus—including a new high horsepower engine sand casting plant set for operation in early 2026—to accommodate customer shifts from China and other suppliers amid US tariff policies and trade tensions, with capital expenditures elevated at approximately HK$600 million in 2025 and sustained high levels into 2026; additionally, new medical end-market products entered mass production driving 50.6% revenue growth in the first half of 2025, high horsepower engine sales surged 48.3% fueled by AI data center demand, and overall revenue rose 2.0% to HK$2,449.9 million for the six months ended 30 June 2025, with adjusted profit attributable to shareholders up 11.6% to HK$359.6 million.